ES8605975A1 - Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas - Google Patents

Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas

Info

Publication number: ES8605975A1
Authority: ES; Spain
Prior art keywords: controlled release; liquid dosage; pharmaceuticals; approximately; dosage formulations
Prior art date: 1984-01-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES539500A

Other languages

English (en)

Spanish (es)

Other versions

ES539500A0 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Battelle Development Corp

Original Assignee

Battelle Development Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-01-13

Filing date

1985-01-11

Publication date

1986-04-01

1985-01-11 Application filed by Battelle Development Corp filed Critical Battelle Development Corp

1986-04-01 Publication of ES8605975A1 publication Critical patent/ES8605975A1/es

1986-04-01 Publication of ES539500A0 publication Critical patent/ES539500A0/es

Status Expired legal-status Critical Current

Links

238000013270 controlled release Methods 0.000 title abstract 3
239000007788 liquid Substances 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000009977 dual effect Effects 0.000 abstract 3
239000002552 dosage form Substances 0.000 abstract 2
230000037406 food intake Effects 0.000 abstract 2
229920002678 cellulose Polymers 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000003925 fat Substances 0.000 abstract 1
235000019534 high fructose corn syrup Nutrition 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000008297 liquid dosage form Substances 0.000 abstract 1
230000008018 melting Effects 0.000 abstract 1
238000002844 melting Methods 0.000 abstract 1
108060006613 prolamin Proteins 0.000 abstract 1
XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1
239000001993 wax Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ES539500A 1984-01-13 1985-01-11 Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas Expired ES8605975A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US57046984A	1984-01-13	1984-01-13

Publications (2)

Publication Number	Publication Date
ES8605975A1 true ES8605975A1 (es)	1986-04-01
ES539500A0 ES539500A0 (es)	1986-04-01

Family

ID=24279767

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES539500A Expired ES8605975A1 (es)	1984-01-13	1985-01-11	Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas

Country Status (11)

Country	Link
EP (1)	EP0169236A1 (2)
JP (1)	JPS61500910A (2)
AU (1)	AU3835885A (2)
CA (1)	CA1239347A (2)
ES (1)	ES8605975A1 (2)
GR (1)	GR850069B (2)
IL (1)	IL74049A0 (2)
IT (1)	IT1184309B (2)
NZ (1)	NZ210785A (2)
WO (1)	WO1985003000A1 (2)
ZA (1)	ZA85239B (2)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0302065B1 (en) *	1986-03-21	1994-08-10	Eurasiam Laboratories, Inc.	Pharmaceutical compositions
SE8605515D0 (sv) *	1986-12-22	1986-12-22	Astra Laekemedel Ab	A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) *	1987-05-08	1989-04-10	Orion Yhtymae Oy	Ny konsistens.
US4853229A (en) *	1987-10-26	1989-08-01	Alza Corporation	Method for adminstering tiny pills
US5030454A (en) *	1987-10-26	1991-07-09	Alza Corporation	Method for delivering drug in tiny pills in liquid carrier
IT1226940B (it) *	1988-09-16	1991-02-22	Recordati Chem Pharm	Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
US5296236A (en) *	1988-09-16	1994-03-22	Recordati S.A., Chemical And Pharmaceutical Company	Controlled release therapeutic system for a liquid pharmaceutical formulations
US5202128A (en) *	1989-01-06	1993-04-13	F. H. Faulding & Co. Limited	Sustained release pharmaceutical composition
DE69220317T2 (de) *	1991-10-01	1997-10-16	Takeda Chemical Industries Ltd	Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
US5160742A (en) *	1991-12-31	1992-11-03	Abbott Laboratories	System for delivering an active substance for sustained release
IL104093A (en) *	1991-12-31	1999-06-20	Abbott Lab	Prolamine is expected to mask the taste of drugs given orally
AU4198793A (en) †	1992-07-24	1994-01-27	Takeda Chemical Industries Ltd.	Microparticle preparation and production thereof
US5744164A (en) *	1994-12-16	1998-04-28	Nestec S.A.	Sustained release microparticulate caffeine formulation
FR2791888B1 (fr) *	1999-04-06	2004-10-08	Ethypharm Lab Prod Ethiques	Suspension pharmaceutique buvable
BR0009557A (pt)	1999-04-06	2002-05-28	Ethypharm Lab Prod Ethiques	Suspensão farmacêutica para beber de ibuprofeno
FR2821745B1 (fr) *	2001-03-09	2004-07-02	Ethypharm Lab Prod Ethiques	Granules et granules enrobes au gout masque
WO2004096175A2 (en) *	2003-04-30	2004-11-11	Ranbaxy Laboratories Limited	Taste masked microcapsules and processes for their preparation
JP6487534B2 (ja)	2014-09-05	2019-03-20	シンビオミックスセラピューティクス、エルエルシー	細菌性膣炎の治療に使用するためのセクニダゾール
US12280037B2 (en)	2020-09-22	2025-04-22	Evofem Biosciences, Inc.	Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2805977A (en) *	1955-01-04	1957-09-10	Smith Kline French Lab	Sustained release pharmaceutical preparation
US3265629A (en) *	1958-12-22	1966-08-09	Ncr Co	Coating by phase separation
US3432593A (en) *	1963-09-18	1969-03-11	Key Pharm Inc	Delayed and sustained release type pharmaceutical preparation

1985
- 1985-01-08 NZ NZ210785A patent/NZ210785A/en unknown
- 1985-01-09 EP EP85900864A patent/EP0169236A1/en not_active Withdrawn
- 1985-01-09 AU AU38358/85A patent/AU3835885A/en not_active Abandoned
- 1985-01-09 JP JP60500315A patent/JPS61500910A/ja active Pending
- 1985-01-09 WO PCT/US1985/000042 patent/WO1985003000A1/en not_active Ceased
- 1985-01-10 ZA ZA85239A patent/ZA85239B/xx unknown
- 1985-01-10 GR GR850069A patent/GR850069B/el unknown
- 1985-01-11 CA CA000471918A patent/CA1239347A/en not_active Expired
- 1985-01-11 IT IT19086/85A patent/IT1184309B/it active
- 1985-01-11 ES ES539500A patent/ES8605975A1/es not_active Expired
- 1985-01-13 IL IL74049A patent/IL74049A0/xx unknown

Also Published As

Publication number	Publication date
IL74049A0 (en)	1985-04-30
ZA85239B (en)	1985-08-28
NZ210785A (en)	1987-11-27
EP0169236A1 (en)	1986-01-29
CA1239347A (en)	1988-07-19
ES539500A0 (es)	1986-04-01
IT8519086A0 (it)	1985-01-11
GR850069B (2)	1985-05-03
WO1985003000A1 (en)	1985-07-18
IT1184309B (it)	1987-10-28
JPS61500910A (ja)	1986-05-08
AU3835885A (en)	1985-07-30

Publication	Publication Date	Title
CA2086847A1 (en)	1993-07-15	Stable, liquid products containing fat-soluble substances
AU586286B2 (en)	1989-07-06	Pharmaceutical and dietary composition
AU4709989A (en)	1990-06-28	Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
TW429153B (en)	2001-04-11	Aerosol compositions
AU1785483A (en)	1984-02-16	Slow release and fast release tablet formulation comprising two active ingredients
EP0171710A3 (en)	1987-05-27	Process for preparing liposome composition
CA2210872A1 (en)	1996-07-25	Dried composition
HK22396A (en)	1996-02-16	Pharmaceutical composition containing felbinac
IE792027L (en)	1980-04-24	Pyrroloazetidinones
IE810036L (en)	1981-07-11	Sustained release compositions
EP0208519A3 (en)	1987-08-12	Solubilized composition of hardly-soluble pharmaceutical product
AU4538489A (en)	1990-05-31	Pharmaceutical compositions
AU3835885A (en)	1985-07-30	Controlled release liquid dosage formulations for pharmaceuticals
CA2067365A1 (en)	1991-04-04	Illudin analogs as anti-tumor agents
CA2046216A1 (en)	1992-01-06	Coating composition for glass containers
CA2128103A1 (en)	1993-07-22	Formulation and use of carotenoids in treatment of cancer
IL65922A0 (en)	1982-08-31	Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them
US5200428A (en)	1993-04-06	Agent for the tsh suppression and treatment of struma
HUT42296A (en)	1987-07-28	Growth regulating compositions containing acetic acid derivatives containing phosphor as active ingredients and process for preparing the active ingredients
CA2015632A1 (en)	1990-11-10	Stable solutions of rebeccamycin analog and preparations thereof
HUT37865A (en)	1986-03-28	Pesticide compositions containing derivatives of alkane-,alkene- or alkadiene-carboxylic acid amides as active substances and process for preparing the active substances
JPS57134414A (en)	1982-08-19	Preparation of sugar-coated tablet
JPS5648857A (en)	1981-05-02	Low-protein feed
GB1261989A (en)	1972-02-02	5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
JPS5441285A (en)	1979-04-02	Liquid crystal composition